Exchange Grants Kolon TissueGene a One-Year Improvement Period

[Asia Economy Reporter Eunmo Koo] The Korea Exchange KOSDAQ Market Committee announced on the 17th through a public notice that it has decided to grant Kolon TissueGene a one-year improvement period. The end date of the improvement period is December 17 of next year, and Kolon TissueGene must submit a report on the implementation of the improvement plan and an expert's verification of the results of the improvement plan within 7 business days after the end of the improvement period. The Exchange plans to hold a KOSDAQ Market Committee meeting within 15 business days from the submission date of the documents to reconsider and decide on the delisting status.

This content was produced with the assistance of AI translation services.